Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

Early Phase 1
1(33.3%)
N/A
1(33.3%)
Phase 1
1(33.3%)
3Total
Early Phase 1(1)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03561376Early Phase 1Recruiting

Zinc Oxide Versus Petrolatum Following Skin Surgery

Role: lead

NCT05408117Not ApplicableRecruiting

Impact of Suture Type on Pigment Disturbances in Patients of Skin of Color

Role: lead

NCT03370406Phase 1Recruiting

Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC

Role: lead

All 3 trials loaded